25 OCT, 2018
with 2 professional course sessions on statistical and pharmacokinetical aspects of biosimilarity assessment (delivered by prominent biosimilar research expert scientists).
26 OCT, 2018
with invited professional presentations, posters and round table session, was focusing on statistical and regulatory perspectives in bio- and nanosimilar development (presented by leading experts from the fields of regulatory, academic and clinical research).
SEMINAR DAY in Nanomedicines
27 OCT, 2018
NEW IN 2018: the 3rd-day programme consisted of professional Seminar sessions regarding current perspectives of bio- and nanosimilar drug development (it was lectured by special international experts from the field of nanotechnology-formulated drug research).